These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery. Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014 [TBL] [Abstract][Full Text] [Related]
7. Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery. Browning MG; Pessoa BM; Khoraki J; Campos GM Curr Obes Rep; 2019 Jun; 8(2):175-184. PubMed ID: 30847736 [TBL] [Abstract][Full Text] [Related]
8. The endogenous preproglucagon system is not essential for gut growth homeostasis in mice. Wismann P; Barkholt P; Secher T; Vrang N; Hansen HB; Jeppesen PB; Baggio LL; Koehler JA; Drucker DJ; Sandoval DA; Jelsing J Mol Metab; 2017 Jul; 6(7):681-692. PubMed ID: 28702324 [TBL] [Abstract][Full Text] [Related]
9. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor. Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973 [TBL] [Abstract][Full Text] [Related]
10. Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice. Lang S; Wei R; Wei T; Gu L; Feng J; Yan H; Yang J; Hong T Peptides; 2020 Sep; 131():170349. PubMed ID: 32561493 [TBL] [Abstract][Full Text] [Related]
11. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice. Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491 [TBL] [Abstract][Full Text] [Related]
12. Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes. Lang S; Yang J; Yang K; Gu L; Cui X; Wei T; Liu J; Le Y; Wang H; Wei R; Hong T BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139602 [TBL] [Abstract][Full Text] [Related]
13. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Baggio LL; Huang Q; Brown TJ; Drucker DJ Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice. Gu W; Lloyd DJ; Chinookswong N; Komorowski R; Sivits G; Graham M; Winters KA; Yan H; Boros LG; Lindberg RA; Véniant MM J Pharmacol Exp Ther; 2011 Jul; 338(1):70-81. PubMed ID: 21471191 [TBL] [Abstract][Full Text] [Related]
15. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency. Wilson-Pérez HE; Chambers AP; Ryan KK; Li B; Sandoval DA; Stoffers D; Drucker DJ; Pérez-Tilve D; Seeley RJ Diabetes; 2013 Jul; 62(7):2380-5. PubMed ID: 23434938 [TBL] [Abstract][Full Text] [Related]
16. Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production. Jun LS; Millican RL; Hawkins ED; Konkol DL; Showalter AD; Christe ME; Michael MD; Sloop KW Diabetes; 2015 Mar; 64(3):819-27. PubMed ID: 25288673 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice. Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250 [TBL] [Abstract][Full Text] [Related]
18. Dietary Fiber Is Essential to Maintain Intestinal Size, L-Cell Secretion, and Intestinal Integrity in Mice. Hunt JE; Hartmann B; Schoonjans K; Holst JJ; Kissow H Front Endocrinol (Lausanne); 2021; 12():640602. PubMed ID: 33716991 [TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed mice. Franklin ZJ; Lafferty RA; Flatt PR; McShane LM; O'Harte FPM; Irwin N Biochimie; 2022 Aug; 199():60-67. PubMed ID: 35439540 [TBL] [Abstract][Full Text] [Related]
20. β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy. Garibay D; McGavigan AK; Lee SA; Ficorilli JV; Cox AL; Michael MD; Sloop KW; Cummings BP Endocrinology; 2016 Sep; 157(9):3405-9. PubMed ID: 27501183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]